FR2884691A1 - Oral composition, useful to prepare food complement to aid fertility and to prevent abortion and embryonic malformations, comprises mixture of antioxidizing agents and mixture of energizing elements - Google Patents
Oral composition, useful to prepare food complement to aid fertility and to prevent abortion and embryonic malformations, comprises mixture of antioxidizing agents and mixture of energizing elements Download PDFInfo
- Publication number
- FR2884691A1 FR2884691A1 FR0503997A FR0503997A FR2884691A1 FR 2884691 A1 FR2884691 A1 FR 2884691A1 FR 0503997 A FR0503997 A FR 0503997A FR 0503997 A FR0503997 A FR 0503997A FR 2884691 A1 FR2884691 A1 FR 2884691A1
- Authority
- FR
- France
- Prior art keywords
- extract
- vitamin
- mixture
- association according
- selenium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 15
- 230000035558 fertility Effects 0.000 title claims description 8
- 230000036244 malformation Effects 0.000 title claims description 7
- 230000000295 complement effect Effects 0.000 title description 2
- 206010000210 abortion Diseases 0.000 title 1
- 231100000176 abortion Toxicity 0.000 title 1
- 230000003064 anti-oxidating effect Effects 0.000 title 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 24
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 22
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 16
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims abstract description 13
- 229910052711 selenium Inorganic materials 0.000 claims abstract description 13
- 239000011669 selenium Substances 0.000 claims abstract description 13
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 12
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 12
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 12
- 239000011718 vitamin C Substances 0.000 claims abstract description 12
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 10
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 10
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 10
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 10
- 239000011709 vitamin E Substances 0.000 claims abstract description 10
- 229940046009 vitamin E Drugs 0.000 claims abstract description 10
- 239000004475 Arginine Substances 0.000 claims abstract description 8
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims abstract description 8
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims abstract description 8
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229910052749 magnesium Inorganic materials 0.000 claims abstract description 8
- 239000011777 magnesium Substances 0.000 claims abstract description 8
- 229960003080 taurine Drugs 0.000 claims abstract description 8
- 239000011701 zinc Substances 0.000 claims abstract description 8
- 229910052725 zinc Inorganic materials 0.000 claims abstract description 8
- 235000016804 zinc Nutrition 0.000 claims abstract description 8
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims abstract description 6
- 150000003839 salts Chemical class 0.000 claims abstract description 6
- 239000000284 extract Substances 0.000 claims description 30
- 235000015872 dietary supplement Nutrition 0.000 claims description 28
- 229940091258 selenium supplement Drugs 0.000 claims description 12
- 208000000995 spontaneous abortion Diseases 0.000 claims description 12
- 102000019197 Superoxide Dismutase Human genes 0.000 claims description 11
- 108010012715 Superoxide dismutase Proteins 0.000 claims description 11
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 claims description 9
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 9
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 claims description 9
- 240000001439 Opuntia Species 0.000 claims description 7
- 235000013389 Opuntia humifusa var. humifusa Nutrition 0.000 claims description 7
- 239000000395 magnesium oxide Substances 0.000 claims description 7
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 claims description 7
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 claims description 7
- WGIWBXUNRXCYRA-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WGIWBXUNRXCYRA-UHFFFAOYSA-H 0.000 claims description 7
- 239000011746 zinc citrate Substances 0.000 claims description 7
- 235000006076 zinc citrate Nutrition 0.000 claims description 7
- 229940068475 zinc citrate Drugs 0.000 claims description 7
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 5
- 241000207199 Citrus Species 0.000 claims description 4
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 claims description 4
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 claims description 4
- 240000007817 Olea europaea Species 0.000 claims description 4
- 235000020971 citrus fruits Nutrition 0.000 claims description 4
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 claims description 4
- 229940094952 green tea extract Drugs 0.000 claims description 4
- 235000020688 green tea extract Nutrition 0.000 claims description 4
- 235000012661 lycopene Nutrition 0.000 claims description 4
- 239000001751 lycopene Substances 0.000 claims description 4
- 229960004999 lycopene Drugs 0.000 claims description 4
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 claims description 4
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 4
- 229960001471 sodium selenite Drugs 0.000 claims description 4
- 239000011781 sodium selenite Substances 0.000 claims description 4
- 235000015921 sodium selenite Nutrition 0.000 claims description 4
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 claims description 4
- 235000019158 vitamin B6 Nutrition 0.000 claims description 4
- 239000011726 vitamin B6 Substances 0.000 claims description 4
- 235000019159 vitamin B9 Nutrition 0.000 claims description 4
- 239000011727 vitamin B9 Substances 0.000 claims description 4
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 claims description 4
- 244000241257 Cucumis melo Species 0.000 claims description 3
- 229930003761 Vitamin B9 Natural products 0.000 claims description 3
- 229940038487 grape extract Drugs 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 230000002265 prevention Effects 0.000 claims description 3
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims description 3
- 229940011671 vitamin b6 Drugs 0.000 claims description 3
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 claims description 2
- 235000013734 beta-carotene Nutrition 0.000 claims description 2
- 239000011648 beta-carotene Substances 0.000 claims description 2
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 claims description 2
- 229960002747 betacarotene Drugs 0.000 claims description 2
- 239000000419 plant extract Substances 0.000 claims description 2
- 235000006708 antioxidants Nutrition 0.000 abstract description 6
- 230000003078 antioxidant effect Effects 0.000 abstract description 3
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 abstract description 2
- 230000000694 effects Effects 0.000 abstract 1
- 230000010534 mechanism of action Effects 0.000 abstract 1
- 230000036542 oxidative stress Effects 0.000 description 10
- 208000000509 infertility Diseases 0.000 description 8
- 230000036512 infertility Effects 0.000 description 8
- 231100000535 infertility Toxicity 0.000 description 8
- 241000219112 Cucumis Species 0.000 description 7
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 6
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 6
- 239000012528 membrane Substances 0.000 description 6
- 206010000234 Abortion spontaneous Diseases 0.000 description 5
- 108020004414 DNA Proteins 0.000 description 5
- 239000002775 capsule Substances 0.000 description 5
- 208000015994 miscarriage Diseases 0.000 description 5
- 229910052760 oxygen Inorganic materials 0.000 description 5
- 239000001301 oxygen Substances 0.000 description 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 150000003254 radicals Chemical class 0.000 description 4
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 4
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 3
- 239000003642 reactive oxygen metabolite Substances 0.000 description 3
- 229960003604 testosterone Drugs 0.000 description 3
- WVXRAFOPTSTNLL-NKWVEPMBSA-N 2',3'-dideoxyadenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1CC[C@@H](CO)O1 WVXRAFOPTSTNLL-NKWVEPMBSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- FFFHZYDWPBMWHY-VKHMYHEASA-N L-homocysteine Chemical compound OC(=O)[C@@H](N)CCS FFFHZYDWPBMWHY-VKHMYHEASA-N 0.000 description 2
- 240000003394 Malpighia glabra Species 0.000 description 2
- 235000014837 Malpighia glabra Nutrition 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- 206010003883 azoospermia Diseases 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000007123 defense Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000001066 destructive effect Effects 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 230000001605 fetal effect Effects 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- -1 hydroxyl radicals Chemical class 0.000 description 2
- 238000002513 implantation Methods 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 210000000287 oocyte Anatomy 0.000 description 2
- 230000004792 oxidative damage Effects 0.000 description 2
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 239000007901 soft capsule Substances 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 229930003799 tocopherol Natural products 0.000 description 2
- 239000011732 tocopherol Substances 0.000 description 2
- 229960001295 tocopherol Drugs 0.000 description 2
- 235000010384 tocopherol Nutrition 0.000 description 2
- 230000003966 vascular damage Effects 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- NVKAWKQGWWIWPM-ABEVXSGRSA-N 17-β-hydroxy-5-α-Androstan-3-one Chemical compound C1C(=O)CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CC[C@H]21 NVKAWKQGWWIWPM-ABEVXSGRSA-N 0.000 description 1
- HGUFODBRKLSHSI-UHFFFAOYSA-N 2,3,7,8-tetrachloro-dibenzo-p-dioxin Chemical compound O1C2=CC(Cl)=C(Cl)C=C2OC2=C1C=C(Cl)C(Cl)=C2 HGUFODBRKLSHSI-UHFFFAOYSA-N 0.000 description 1
- 230000002407 ATP formation Effects 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 206010067162 Asthenospermia Diseases 0.000 description 1
- 208000000412 Avitaminosis Diseases 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 101100310593 Candida albicans (strain SC5314 / ATCC MYA-2876) SOD4 gene Proteins 0.000 description 1
- 208000037088 Chromosome Breakage Diseases 0.000 description 1
- 235000009842 Cucumis melo Nutrition 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 102000006587 Glutathione peroxidase Human genes 0.000 description 1
- 108700016172 Glutathione peroxidases Proteins 0.000 description 1
- 206010019273 Heart disease congenital Diseases 0.000 description 1
- 206010021135 Hypovitaminosis Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 102000008109 Mixed Function Oxygenases Human genes 0.000 description 1
- 108010074633 Mixed Function Oxygenases Proteins 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 206010067572 Oestrogenic effect Diseases 0.000 description 1
- 206010039921 Selenium deficiency Diseases 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 201000010829 Spina bifida Diseases 0.000 description 1
- 208000006097 Spinal Dysraphism Diseases 0.000 description 1
- 206010050208 Teratospermia Diseases 0.000 description 1
- 208000002312 Teratozoospermia Diseases 0.000 description 1
- 101100096123 Zantedeschia aethiopica SODCP gene Proteins 0.000 description 1
- 206010048259 Zinc deficiency Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- 102000001307 androgen receptors Human genes 0.000 description 1
- 108010080146 androgen receptors Proteins 0.000 description 1
- 229960003473 androstanolone Drugs 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 229940093797 bioflavonoids Drugs 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 208000028831 congenital heart disease Diseases 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000003412 degenerative effect Effects 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 230000001076 estrogenic effect Effects 0.000 description 1
- 210000005002 female reproductive tract Anatomy 0.000 description 1
- 210000003495 flagella Anatomy 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 208000021267 infertility disease Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000002248 lipoperoxidative effect Effects 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 230000023508 male gonad development Effects 0.000 description 1
- 210000005001 male reproductive tract Anatomy 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 210000000276 neural tube Anatomy 0.000 description 1
- 201000010193 neural tube defect Diseases 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000002417 nutraceutical Substances 0.000 description 1
- 235000021436 nutraceutical agent Nutrition 0.000 description 1
- 235000003170 nutritional factors Nutrition 0.000 description 1
- 208000008634 oligospermia Diseases 0.000 description 1
- 230000036616 oligospermia Effects 0.000 description 1
- 231100000528 oligospermia Toxicity 0.000 description 1
- 230000034004 oogenesis Effects 0.000 description 1
- 230000016087 ovulation Effects 0.000 description 1
- 150000002926 oxygen Chemical class 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- UUZZMWZGAZGXSF-UHFFFAOYSA-N peroxynitric acid Chemical compound OON(=O)=O UUZZMWZGAZGXSF-UHFFFAOYSA-N 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000002831 pharmacologic agent Substances 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000019100 sperm motility Effects 0.000 description 1
- 230000021595 spermatogenesis Effects 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 229940032362 superoxide dismutase Drugs 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 208000035581 susceptibility to neural tube defects Diseases 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 208000030401 vitamin deficiency disease Diseases 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000002676 xenobiotic agent Substances 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/33—Cactaceae (Cactus family), e.g. pricklypear or Cereus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
Description
2884691 12884691 1
L'invention concerne de nouveaux compléments alimentaires qui sont utiles comme aide à la fertilité chez l'homme et chez la femme. The present invention relates to novel dietary supplements that are useful as aids to fertility in men and women.
Les causes d'une infertilité se recherchent à quatre niveaux: qualité du sperme, ovulations, voies génitales féminines et masculines, et incompatibilité entre le sperme et 10 le milieu génital féminin. The causes of infertility are sought at four levels: sperm quality, ovulation, female and male genital tract, and incompatibility between sperm and female genital environment.
De nombreuses études ont permis de mettre en évidence le déclin de la qualité du sperme des hommes fertiles, depuis une vingtaine d'années, ce qui entraînerait une altération de la fécondité dans les années à venir. Numerous studies have demonstrated the decline in sperm quality of fertile men over the last twenty years, which would lead to an alteration of fertility in the years to come.
La question de l'infertilité conjugale doit faire prendre conscience de l'incidence 15 sur la fertilité masculine et féminine des facteurs liés à l'environnement et des facteurs nutritionnels. The issue of marital infertility must raise awareness of the impact on male and female fertility of environmental factors and nutritional factors.
Dans les pays industriels, 15 % des couples sont inféconds dont les causes identifiées sont diverses mais une grande proportion ne montre aucune anomalie au niveau de chacun des deux conjoints et cependant ils n'arrivent pas à concevoir un enfant: c'est l'infécondité inexpliquée. In industrialized countries, 15% of couples are infertile whose causes are identified but a large proportion show no anomaly at the level of each of the two spouses and yet they fail to conceive a child: it is infertility unexplained.
L'infécondité peut avoir pour origine l'action des agents toxiques, pesticides (dioxine avec effet oestrogénique par blocage des récepteurs aux androgènes), les métaux lourds, le tabac (par le biais des radicaux libres), l'alcool, les agents pharmacologiques, les rayons X et gamma, les hormones (absorbées par le bétail puis consommées ensuite par les humains), l'infection ou l'inflammation. Ces facteurs sont susceptibles d'entraîner l'apparition d'un stress oxydatif. Le stress oxydatif est, dans ce contexte, l'intermédiaire dans l'infécondité. Infertility can be caused by the action of toxic agents, pesticides (dioxin with estrogenic effect by blocking androgen receptors), heavy metals, tobacco (through free radicals), alcohol, pharmacological agents , X and gamma rays, hormones (absorbed by livestock and then consumed by humans), infection or inflammation. These factors are likely to lead to the onset of oxidative stress. Oxidative stress is, in this context, the intermediary in infertility.
Explication du stress oxydatif: 98% de l'oxygène inspiré est réduit en molécules d'eau par capture de quatre électrons et s'accompagne de formation d'A.T.P., qui est à l'origine de la production d'énergie par la cellule pour sa défense, sa mobilité, sa reproduction. Mais dans 2% de cas, il y a une fuite d'électrons, qui entrent directement en rapport avec l'oxygène. Cet oxygène va être affecter d'un électron célibataire, ce qui 2884691 2 va aboutir à la formation d'espèces oxygénées réactives toxiques. C'est ainsi que naissent: - l'anion superoxyde; le peroxyde d'hydrogène; l'acide péroxynitrique; et - l'oxygène singulet. Oxidative stress explanation: 98% of inspired oxygen is reduced to water molecules by capture of four electrons and is accompanied by ATP formation, which is responsible for the production of energy by the cell for his defense, his mobility, his reproduction. But in 2% of cases, there is a leak of electrons, which are directly related to oxygen. This oxygen will be assigned to a single electron, which will result in the formation of toxic reactive oxygen species. Thus are born: - the superoxide anion; hydrogen peroxide; peroxynitric acid; and singlet oxygen.
Le stress oxydatif peut s'aggraver à l'occasion de certaines situations: pollution, xénobiotiques, surexposition au soleil, irradiations, conditions infectieuses, inflammatoires ou dégénératives. D'autre part, le vieillissement s'accompagne d'une altération du transport des électrons et donc d'une augmentation des espèces oxygénées réactives. Oxidative stress can worsen in certain situations: pollution, xenobiotics, overexposure to the sun, irradiation, infectious, inflammatory or degenerative conditions. On the other hand, the aging is accompanied by an alteration of the electron transport and thus an increase of reactive oxygen species.
En réponse à la formation d'espèces oxygénées, notre organisme a développé des lignes de défense nous protégeant des effets nocifs des espèces oxygénées réactives par combinaison d'agent antioxydants avec les radicaux libres pour former des dérivés 15 oxydés neutres. In response to the formation of oxygenated species, our organism has developed defense lines protecting us from the harmful effects of reactive oxygen species by combining antioxidants with free radicals to form neutral oxidized derivatives.
Le stress oxydatif résulte du déséquilibre entre les espèces oxygénées destructrices et les antioxydants protecteurs (espèces oxygénées destructrices > antioxydants protecteurs). Oxidative stress results from the imbalance between destructive oxygen species and protective antioxidants (destructive oxygen species> protective antioxidants).
Les conséquences possibles du stress oxydatif sur la fécondité sont les suivantes: 20 1) Cassures au niveau des chromosomes altérant le message génétique (mesuré par l'index de fragmentation de l'ADN du spermatozoïde (DFI)) ; 2) Péroxydation des acides gras polyinsaturés des membranes cellulaires entraînant un déficit de la perméabilité et des troubles dans les échanges pouvant aller jusqu'à la mort cellulaire. The possible consequences of oxidative stress on fertility are as follows: (1) Chromosome breaks in the genetic message (measured by sperm DNA fragmentation index (DFI)); 2) Peroxidation of the polyunsaturated fatty acids of the cellular membranes causing a deficiency of the permeability and disorders in the exchanges up to the cell death.
Chez l'homme, le stress oxydatif va affecter: - la concentration du sperme (oligospermie > azoospermie) la mobilité des spermatozoïdes (asthénospermie, moins de 40 % de spermatozoïdes mobiles) - la morphologie des spermatozoïdes (tératospermie, moins de 30 % de 30 spermatozoïdes normaux) Chez la femme, le stress oxydatif peut entraîner sur l'ovocyte les mêmes inconvénients que pour le spermatozoïde (attaque de l'ADN et des acides gras 2884691 3 polyinsaturés de la membrane). En outre, la femme est exposée à des risques spécifiques, selon le déficit en certains antioxydants. C'est ainsi que le déficit de sélénium (qui s'accompagne d'une baisse du glutathion peroxydase) pourrait entraîner une fausse couche par suite des dégâts oxydatifs directs sur les membranes et l'ADN du foetus. Le déficit en vitamines B6, B9 et B12 peut également entraîner une fausse couche, cette fois par le biais de l'élévation de l'homocystéine (dégâts vasculaires précoces au niveau de la nidation). Le risque de fausse couche peut de nouveau être amplifié lorsqu'il y a un déficit en zinc (répercussion sur l'ovogenèse). Enfin, le déficit en vitamines B6 et B9 et en zinc peut entraîner chez le foetus des malformations du tube neural (spina bifida) ainsi que des malformations vésicales et cardiaques. In humans, oxidative stress will affect: - sperm concentration (oligospermia> azoospermia) sperm motility (asthenospermia, less than 40% motile spermatozoa) - sperm morphology (teratospermia, less than 30% of spermatozoa) normal sperm) In women, oxidative stress can cause the same problems for the oocyte as for the spermatozoon (attack of DNA and polyunsaturated fatty acids of the membrane). In addition, the woman is exposed to specific risks, depending on the deficit in certain antioxidants. For example, selenium deficiency (which is associated with a decrease in glutathione peroxidase) could lead to miscarriage as a result of direct oxidative damage to membranes and fetal DNA. Vitamin deficiency B6, B9 and B12 can also lead to miscarriage, this time through the elevation of homocysteine (early vascular damage to implantation). The risk of miscarriage can be further amplified when there is a zinc deficiency (repercussion on oogenesis). Finally, deficiency of vitamins B6 and B9 and zinc can cause fetal neural tube defects (spina bifida) as well as vesical and heart malformations.
L'invention a pour objet un complément alimentaire qui permet de lutter contre le stress oxydatif et ainsi d'aider à la fertilité masculine ou féminine, et de réduire les risques de fausse couche et de malformation. The subject of the invention is a dietary supplement which makes it possible to combat oxidative stress and thus to help male or female fertility, and to reduce the risks of miscarriage and malformation.
L'invention concerne donc un complément alimentaire, destiné à une administration par voie orale, comprenant une association: (a) d'un mélange d'agents antioxydants constitué de la vitamine C, de la vitamine E, de superoxyde dismutase, du zinc, sous forme de sels ou de 20 complexes, et du sélénium; et (b) d'un mélange d'éléments énergisants constitué du magnésium, sous forme de sels ou de complexes, de l'arginine et de la taurine. The invention therefore relates to a dietary supplement, intended for oral administration, comprising a combination of: (a) a mixture of antioxidant agents consisting of vitamin C, vitamin E, superoxide dismutase, zinc, in the form of salts or complexes, and selenium; and (b) a mixture of energizing elements consisting of magnesium, salts or complexes, arginine and taurine.
La vitamine C permet de protéger l'ADN des radicaux libres et de protéger les hydroxylases indispensables à la production d'énergie. Dans un mode de réalisation particulier de la présente invention, la source de vitamine C est un extrait naturel, en particulier un extrait d'acerola. Selon une caractéristique particulière de la présente invention, le complément alimentaire comprend 30 à 120 mg de vitamine C, avantageusement 30 mg de vitamine C. La vitamine E permet de protéger la membrane lipidique contre la lipopéroxydation et permet ainsi d'apporter une stabilisation membranaire. Selon une caractéristique particulière de la présente invention, le complément alimentaire comprend 3 à 7 mg de vitamine E. 2884691 4 Le superoxyde dismutase (SOD) est une enzyme qui élimine les radicaux hydroxyles et bloque ainsi le processus de formation des radicaux libres dès son début. La SOD peut être d'origine animale (bovine par exemple) ou végétale. En particulier, la SOD est présente dans le melon (cucumis melo). Vitamin C protects the DNA from free radicals and protects the essential hydroxylases for energy production. In a particular embodiment of the present invention, the source of vitamin C is a natural extract, in particular an acerola extract. According to one particular characteristic of the present invention, the dietary supplement comprises 30 to 120 mg of vitamin C, advantageously 30 mg of vitamin C. Vitamin E makes it possible to protect the lipid membrane against lipoperoxidation and thus makes it possible to provide membrane stabilization. According to one particular characteristic of the present invention, the dietary supplement comprises 3 to 7 mg of vitamin E. Superoxide dismutase (SOD) is an enzyme which eliminates hydroxyl radicals and thus blocks the free radical formation process from its very beginning. . SOD can be of animal (bovine for example) or vegetable origin. In particular, SOD is present in melon (cucumis melo).
Dans le complément alimentaire selon l'invention, on introduit avantageusement, en tant que source de superoxyde dismutase, un extrait de melon, plus particulièrement de 5 à 20 mg d'extrait de melon, avantageusement 5 mg d'extrait de melon. In the dietary supplement according to the invention, a melon extract, more particularly 5 to 20 mg of melon extract, advantageously 5 mg of melon extract, is advantageously introduced as a source of superoxide dismutase.
Le zinc joue un rôle dans le développement testiculaire, notamment dans la transformation de la testostérone en DHT (dihydrotestostérone, forme active de la testostérone). Le zinc se présente avantageusement sous forme de sel de zinc, tel que le citrate de zinc, ou sous forme d'un complexe. Dans une variante avantageuse de l'invention, le complément alimentaire comprend 12 à 25 mg, avantageusement 25 mg, de citrate de zinc. Zinc plays a role in testicular development, especially in the transformation of testosterone into DHT (dihydrotestosterone, active form of testosterone). Zinc is advantageously in the form of a zinc salt, such as zinc citrate, or in the form of a complex. In an advantageous variant of the invention, the dietary supplement comprises 12 to 25 mg, advantageously 25 mg, of zinc citrate.
Le sélénium joue un rôle dans la biosynthèse de la testostérone et donc de la spermatogenèse. Il permet de préserver l'intégrité du flagelle. Il est avantageusement introduit dans le complément alimentaire sous la forme d'extraits de levures nourries au sélénium ou de sélénite de sodium. Selon une variante de l'invention, il est introduit dans le complément alimentaire sous la forme de sélénite de sodium, avantageusement en une quantité variant de 0,042 à 0,084 mg. Selon une autre variante de l'invention, il est introduit dans le complément alimentaire sous la forme d'extraits de levures nourries au sélénium (entre 15 et 20 mg, avantageusement 18,75 mg, d'extraits de levures). Selenium plays a role in the biosynthesis of testosterone and therefore spermatogenesis. It preserves the integrity of the flagellum. It is advantageously introduced into the dietary supplement in the form of extracts of yeasts fed selenium or sodium selenite. According to a variant of the invention, it is introduced into the dietary supplement in the form of sodium selenite, advantageously in an amount ranging from 0.042 to 0.084 mg. According to another variant of the invention, it is introduced into the dietary supplement in the form of selenium-fed yeast extracts (between 15 and 20 mg, advantageously 18.75 mg of yeast extracts).
Le magnésium est un élément énergisant. Il permet de lutter contre l'asthénie des spermatozoïdes. Il est avantageusement introduit dans le complément alimentaire sous la forme d'oxyde de magnésium (apport exogène) . Le complément alimentaire selon l'invention comprend alors avantageusement 80 à 300 mg, plus avantageusement 249 mg, d'oxyde de magnésium. Magnesium is an energizing element. It helps to fight against the asthenia of spermatozoa. It is advantageously introduced into the dietary supplement in the form of magnesium oxide (exogenous supply). The food supplement according to the invention then advantageously comprises 80 to 300 mg, more advantageously 249 mg, of magnesium oxide.
La taurine et l'arginine permettent de retenir le magnésium, dont l'élimination dans l'organisme est rapide. Ainsi, le magnésium reste disponible plus longtemps dans l'organisme humain. Selon une variante avantageuse de l'invention, la source de taurine et/ou d'arginine est au moins un extrait naturel, encore plus avantageusement un extrait de plante. En particulier, la source de taurine et d'arginine est un extrait de figue de barbarie. Dans cette variante, le complément alimentaire comprend avantageusement 50 2884691 5 à 200 mg d'extrait de figue de barbarie, encore plus avantageusement 50 mg d'extrait de figue de barbarie. Taurine and arginine help retain magnesium, which is rapidly eliminated in the body. Thus, magnesium remains available longer in the human body. According to an advantageous variant of the invention, the source of taurine and / or arginine is at least one natural extract, still more advantageously a plant extract. In particular, the source of taurine and arginine is an extract of prickly pear. In this variant, the dietary supplement advantageously comprises 50 to 200 mg of prickly pear extract, and still more advantageously 50 mg of prickly pear extract.
Selon une variante préférée de l'invention, le complément alimentaire comprend: - 30 mg de vitamine C; - 5 mg de vitamine E; - 18, 75 mg de sélénium sur levures; - 25 mg de citrate de zinc; - 5 mg d'extrait de melon (SOD) - 249 mg d'oxyde de magnésium; - 50 mg d'extrait de figue de barbarie. According to a preferred variant of the invention, the dietary supplement comprises: - 30 mg of vitamin C; - 5 mg of vitamin E; 18.75 mg of selenium on yeasts; - 25 mg of zinc citrate; - 5 mg of melon extract (SOD) - 249 mg of magnesium oxide; - 50 mg of prickly pear extract.
Dans le cadre de la présente invention, le complément alimentaire comprend également (c) au moins un autre agent antioxydant choisi dans le groupe constitué par un extrait de thé vert, un extrait d'olive, un extrait de citrus, du béta-carotène, du lycopène, la vitamine B6 (qui dans le contexte de l'invention joue le rôle d'agent antioxydant et qui renforce l'action anti-oxydante du groupe (a)), la vitamine B9 (qui dans le contexte de l'invention permet de prévenir les malformations), un extrait de raisin, de la levure de bière (qui permet l'apport de glutathion en quantités faibles, de l'ordre de traces), et leurs mélanges. In the context of the present invention, the food supplement also comprises (c) at least one other antioxidant agent selected from the group consisting of a green tea extract, an olive extract, a citrus extract, beta-carotene, lycopene, vitamin B6 (which in the context of the invention acts as an antioxidant and reinforces the antioxidant action of group (a)), vitamin B9 (which in the context of the invention prevents malformation), grape extract, brewer's yeast (which allows glutathione intake in small amounts, in the order of traces), and their mixtures.
L'invention concerne également l'utilisation du complément alimentaire selon l'invention dans le traitement de l'infertilité (masculine ou féminine), notamment de l'infertilité conjugale. Le complément alimentaire selon l'invention est efficace pour l'aide à la fertilité, en raison notamment de son rôle préventif envers le stress oxydatif. The invention also relates to the use of the food supplement according to the invention in the treatment of infertility (male or female), in particular marital infertility. The dietary supplement according to the invention is effective for the support of fertility, particularly because of its preventive role against oxidative stress.
L'invention concerne également l'utilisation du complément alimentaire selon l'invention dans la prévention des fausses couches, en particulier des fausses couches précoces, et des malformations embryonnaires. The invention also relates to the use of the food supplement according to the invention in the prevention of miscarriages, in particular early miscarriages, and embryonic malformations.
Le complément alimentaire selon l'invention permet d'assurer la protection des spermatozoïdes et des ovocytes. De plus, il permet de prévenir les dégâts oxydatifs (sur les membranes, sur l'ADN) sur l'embryon et diminue ainsi le risque de fausses couches. The dietary supplement according to the invention makes it possible to ensure the protection of spermatozoa and oocytes. In addition, it prevents oxidative damage (on membranes, DNA) on the embryo and thus reduces the risk of miscarriage.
Le complément selon l'invention permet également de prévenir les risques de dégâts vasculaires précoces au niveau de la nidation (empêcher une élévation de 2884691 6 l'homocystéine) et ainsi il permet également, par le biais de ce deuxième mécanisme, de diminuer le risque de fausses couches, notamment de fausses couches précoces. The complement according to the invention also makes it possible to prevent the risk of early vascular damage at the level of implantation (to prevent a rise in homocysteine) and thus it also makes it possible, by means of this second mechanism, to reduce the risk miscarriages, including early miscarriages.
Ainsi, ledit complément permet avantageusement de réduire les risques de fausses couches précoces et les risques de malformations embryonnaires, notamment les 5 malformations: - du tube neural; -vésicales; - cardiaques. Thus, the said supplement advantageously makes it possible to reduce the risks of early miscarriages and the risks of embryonic malformations, in particular the 5 malformations: of the neural tube; -vésicales; - heart.
Les différents composés du complément alimentaire peuvent être administrés 10 simultanément (dans un même comprimé par exemple) ou comme produits de combinaison pour une utilisation séparée ou étalée dans le temps. The different compounds of the dietary supplement can be administered simultaneously (in the same tablet for example) or as combination products for separate use or spread over time.
Le complément alimentaire est formulé pour être administré par voie orale. Il peut ainsi se présenter sous forme de capsule, gélule, comprimé, granule, avantageusement sous la forme de comprimé. Lorsque le complément alimentaire se présente sous forme de capsule molle ou de gélule, l'enveloppe de ces capsules molles ou de ces gélules peut contenir notamment de la gélatine animale telle que la gélatine de poisson, de la glycérine, ou un matériau d'origine végétale tel qu'un dérivé de cellulose ou d'amidon, ou une protéine végétale. Lorsque le complément alimentaire se présente sous forme de gélule, de comprimé, ou de granule, le mélange d'actifs peut être fixé sur un support pulvérulent tel que la silice, la cellulose, et la maltodextrine. The dietary supplement is formulated to be administered orally. It can thus be in the form of capsule, capsule, tablet, granule, advantageously in the form of tablet. When the food supplement is in the form of soft capsule or capsule, the envelope of these soft capsules or capsules may contain in particular animal gelatin such as fish gelatin, glycerin, or a source material plant such as a cellulose or starch derivative, or a vegetable protein. When the dietary supplement is in capsule, tablet, or granule form, the active mixture can be attached to a powdery carrier such as silica, cellulose, and maltodextrin.
Selon une variante de l'invention, les conseils d'utilisation sont de deux doses par jour (pour le père et/ou la mère). Selon cette variante, le complément alimentaire est titré de manière à permettre l'administration d'une dose journalière d'environ 250 mg de magnésium par jour, d'environ 60 mg de vitamine C par jour, d'environ 10 mg de vitamine E par jour, d'environ 15 mg de zinc par jour et d'environ 75 g de sélénium par jour. According to a variant of the invention, the instructions for use are two doses per day (for the father and / or the mother). According to this variant, the dietary supplement is titrated to allow the administration of a daily dose of about 250 mg of magnesium per day, about 60 mg of vitamin C per day, about 10 mg of vitamin E per day, about 15 mg of zinc per day and about 75 g of selenium per day.
Avantageusement selon la présente invention, le complément alimentaire peut comprendre tout véhicule ou excipient approprié, acceptable du point de vue nutraceutique, ainsi que des additifs conventionnels, connus de l'homme du métier. Advantageously according to the present invention, the dietary supplement may comprise any suitable vehicle or excipient, acceptable from a nutraceutical point of view, as well as conventional additives, known to those skilled in the art.
Les exemples suivants sont destinés à illustrer l'invention sans aucunement en limiter la portée. The following examples are intended to illustrate the invention without in any way limiting its scope.
2884691 7 Exemple 1: complément alimentaire selon l'invention INGRÉDIENTS Quantité (mg) Oxyde de magnésium' 249 Acerola naturel2 120 Levure de bière 80 Extrait de figue de barbarie 50 Extrait de raisin 35 Thé vert extrait 35 Olive fruit extrait 35 Citrate de zinc 25 Citrus extrait (bioflavonoïdes) 25 Béta-carotène naturel (7,5%) 20 Sélénium sur levure 18,75 Vitamine E naturelle (y tocophérol) 3,5 Vitamine E naturelle (33 tocophérol) 1,5 Extrait de Melon SOD4 5 Lycopène à 5%5 1 Vitamine B6 1 Vitamine B9 0,1 Cellulose microcristalline QS Dextrose QS Stéarate de magnésium QS QS = quantité suffisante 160,3 % d'ion Mg2+ 230 mg d'élément (vitamine C) 375 g d'élément sélénium 4 SOD = super oxyde dismutase 550 g d'élément lycopène Cette composition est formulée sous la forme de comprimés sécables. 2884691 7 Example 1: Dietary supplement according to the invention INGREDIENTS Amount (mg) Magnesium oxide '249 Acerola natural2 120 Beer yeast 80 Prickly pear extract 50 Grape extract 35 Green tea extract 35 Olive fruit extract 35 Zinc citrate 25 Citrus extract (bioflavonoids) Beta-carotene natural (7.5%) Selenium on yeast 18.75 Natural vitamin E (y tocopherol) 3.5 Natural vitamin E (33 tocopherol) 1.5 Melon extract SOD4 5 Lycopene 5% 5 1 Vitamin B6 1 Vitamin B9 0.1 Microcrystalline cellulose QS Dextrose QS Magnesium stearate QS QS = sufficient quantity 160.3% Mg2 + ion 230 mg element (vitamin C) 375 g element selenium 4 SOD = super oxide dismutase 550 g of lycopene element This composition is formulated in the form of breakable tablets.
Dans le traitement de l'infertilité conjugale, les conseils d'utilisation sont de deux comprimés par jour pour le père et de deux comprimés par jour pour la mère. In the treatment of conjugal infertility, the usage tips are two tablets a day for the father and two tablets a day for the mother.
Exemple 2: complément alimentaire selon l'invention Comprimé de 685,65 mg ayant la composition pondérale suivante: Vitamine C naturelle Oxyde de magnésium Figue de barbarie Citrate de zinc Alpha tocophérol Chlorhydrate de pyridoxine Acide Folique Sélénite de sodium Levure de bière Marc de raisin OPC Extrait de thé vert Extrait d'olive fruit Extrait de citrus Bêta carotène naturel Extrait de melon Extrait de tomate 30-120 mg 80-250 mg 50-200 mg 12-25 mg 3-7mg 0,5-lmg 0,05- l mg 0, 042-0,085mg 80mg 160mg 3 Omg-100mg 3 Omg-100mg 3 Omg-100mg 25mg-75mg 20mg-60mg 5mg-20mg 1 mg-3mg Example 2: Dietary supplement according to the invention 685.65 mg tablet having the following composition by weight: Natural vitamin C Magnesium oxide Prickly pear Zinc citrate Alpha tocopherol Pyridoxine hydrochloride Folic acid Sodium selenite Brewer's yeast Marc de grain OPC Green tea extract Olive fruit extract Citrus extract Beta carotene natural Melon extract Tomato extract 30-120 mg 80-250 mg 50-200 mg 12-25 mg 3-7mg 0.5-lmg 0.05- l mg 0, 042-0,085mg 80mg 160mg 3 Omg-100mg 3 Omg-100mg 3 Omg-100mg 25mg-75mg 20mg-60mg 5mg-20mg 1mg-3mg
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0503997A FR2884691B1 (en) | 2005-04-21 | 2005-04-21 | FOOD SUPPLEMENT COMPRISING A COMBINATION OF ANTIOXIDANT AGENTS AND ENERGY AGENTS USEFUL AS AID FOR FERTILITY IN MAN AND IN WOMEN |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0503997A FR2884691B1 (en) | 2005-04-21 | 2005-04-21 | FOOD SUPPLEMENT COMPRISING A COMBINATION OF ANTIOXIDANT AGENTS AND ENERGY AGENTS USEFUL AS AID FOR FERTILITY IN MAN AND IN WOMEN |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2884691A1 true FR2884691A1 (en) | 2006-10-27 |
FR2884691B1 FR2884691B1 (en) | 2007-07-20 |
Family
ID=35149248
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR0503997A Expired - Fee Related FR2884691B1 (en) | 2005-04-21 | 2005-04-21 | FOOD SUPPLEMENT COMPRISING A COMBINATION OF ANTIOXIDANT AGENTS AND ENERGY AGENTS USEFUL AS AID FOR FERTILITY IN MAN AND IN WOMEN |
Country Status (1)
Country | Link |
---|---|
FR (1) | FR2884691B1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2964834A1 (en) * | 2010-09-21 | 2012-03-23 | Marc Cohen | Antioxidant composition, useful as food supplement and to prevent and/or treat infertility, protect sperm and prevent spontaneous abortion/embryonic malformations, comprises prickly pear extract, vitamins B6, B9 and B12 and zinc |
US20140212571A1 (en) * | 2011-10-04 | 2014-07-31 | Oriental Yeast Co., Ltd. | Method for producing high-zinc-content yeast extract, high-zinc-content yeast extract, foods, and agent for maintaining and restoring green color of vegetables |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102007053369A1 (en) * | 2007-11-09 | 2009-07-02 | Alzchem Trostberg Gmbh | Use of a preparation containing a creatine-component and a further component of e.g. L-carnitine, acetyl-L-carnitine, arginine, glutathione, vitamin C and vitamin E, as a dietary supplement for improving the male fertility in vertebrates |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2289406A (en) * | 1994-04-15 | 1995-11-22 | Britannia Health Products Ltd | Vitamin, betacarotene and zinc composition for sperm health |
EP1163904A1 (en) * | 2000-06-16 | 2001-12-19 | Rath, Matthias, Dr. med. | Composition for the prevention of smooth muscle diseases comprising ascorbate, arginine and magnesium |
US20020122834A1 (en) * | 2000-12-22 | 2002-09-05 | Trant Aileen Sontag | Method and composition for improving fertility health in female and male animals and humans |
US6569857B1 (en) * | 1999-05-03 | 2003-05-27 | Drugtech Corporation | Dietary supplement |
US6579544B1 (en) * | 2000-05-31 | 2003-06-17 | Nutriex, L.L.C. | Method for supplementing the diet |
WO2003066573A1 (en) * | 2002-02-04 | 2003-08-14 | Aldo Fassi | Metal salts of carnitines, dietary supplements containing same and dietary kits for counteracing sexual disorders in male subjects |
-
2005
- 2005-04-21 FR FR0503997A patent/FR2884691B1/en not_active Expired - Fee Related
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2289406A (en) * | 1994-04-15 | 1995-11-22 | Britannia Health Products Ltd | Vitamin, betacarotene and zinc composition for sperm health |
US6569857B1 (en) * | 1999-05-03 | 2003-05-27 | Drugtech Corporation | Dietary supplement |
US6579544B1 (en) * | 2000-05-31 | 2003-06-17 | Nutriex, L.L.C. | Method for supplementing the diet |
EP1163904A1 (en) * | 2000-06-16 | 2001-12-19 | Rath, Matthias, Dr. med. | Composition for the prevention of smooth muscle diseases comprising ascorbate, arginine and magnesium |
US20020122834A1 (en) * | 2000-12-22 | 2002-09-05 | Trant Aileen Sontag | Method and composition for improving fertility health in female and male animals and humans |
WO2003066573A1 (en) * | 2002-02-04 | 2003-08-14 | Aldo Fassi | Metal salts of carnitines, dietary supplements containing same and dietary kits for counteracing sexual disorders in male subjects |
Non-Patent Citations (1)
Title |
---|
SINCLAIR S: "MALE INFERTILITY: NUTRITIONAL AND ENVIRONMENTAL CONSIDERATIONS", ALTERNATIVE MEDICINE REVIEW, THORNE RESEARCH INC., SANDPOINT,, US, vol. 5, no. 1, 2000, pages 28 - 38, XP008014042, ISSN: 1089-5159 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2964834A1 (en) * | 2010-09-21 | 2012-03-23 | Marc Cohen | Antioxidant composition, useful as food supplement and to prevent and/or treat infertility, protect sperm and prevent spontaneous abortion/embryonic malformations, comprises prickly pear extract, vitamins B6, B9 and B12 and zinc |
US20140212571A1 (en) * | 2011-10-04 | 2014-07-31 | Oriental Yeast Co., Ltd. | Method for producing high-zinc-content yeast extract, high-zinc-content yeast extract, foods, and agent for maintaining and restoring green color of vegetables |
US9185926B2 (en) * | 2011-10-04 | 2015-11-17 | Oriental Yeast Co., Ltd. | High-zinc yeast extract, method of producing same and agents and foods containing same |
Also Published As
Publication number | Publication date |
---|---|
FR2884691B1 (en) | 2007-07-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1714658B1 (en) | Dietary supplement comprising antioxidant agents and carnitine or a precursor thereof, to be used as an aid to fertility in men and women | |
Erejuwa et al. | Antioxidant protection of Malaysian tualang honey in pancreas of normal and streptozotocin-induced diabetic rats | |
Sung et al. | Effect of lutein on L-NAME-induced hypertensive rats | |
FR2964834A1 (en) | Antioxidant composition, useful as food supplement and to prevent and/or treat infertility, protect sperm and prevent spontaneous abortion/embryonic malformations, comprises prickly pear extract, vitamins B6, B9 and B12 and zinc | |
US20040219239A1 (en) | Nutritional supplement based on blackcurrent seed oil | |
El Ghazzawy et al. | Histological study of the possible protective effect of pomegranate juice on bisphenol-A induced changes of the caput epididymal epithelium and sperms of adult albino rats | |
KR101439859B1 (en) | Beverage composition for improvement of benign prostatic hyperplasia using blackraspberry extracts | |
Raji et al. | Reproductive functions in male rats treated with methanolic extract of Alstonia boonei stem bark | |
US10124029B2 (en) | Oral compositions and route of administration for the delivery of a thylakoid extract | |
Zhao et al. | Protective effects of fucoidan against ethanol-induced liver injury through maintaining mitochondrial function and mitophagy balance in rats | |
Ostovan et al. | Investigating the effects of Citrullus colocynthis pulp on oxidative stress in testes and epididymis in streptozotocin-induced diabetic male rats | |
FR2884691A1 (en) | Oral composition, useful to prepare food complement to aid fertility and to prevent abortion and embryonic malformations, comprises mixture of antioxidizing agents and mixture of energizing elements | |
Kolawole et al. | Ameliorative effects of hydromethanolic extract of Citrullus lanatus (watermelon) rind on semen parameters, reproductive hormones and testicular oxidative status following nicotine administration in male Wistar rats | |
Gadallah et al. | Role of antioxidants in the treatment of male infertility | |
EP3269389B1 (en) | Composition comprising l-carnitine for the treatment of male infertility | |
EP3675960A1 (en) | Composition for use of same in the treatment and/or prevention of infertility | |
WO2002039973A2 (en) | Product preparing and protecting the skin against uv radiation, countering cellular ageing and exerting an immunostimulant action | |
WO2005051370A1 (en) | Composition having liver function protective effect | |
KR20180009627A (en) | Composition for improving male reproduction capability comprising anthocyanin nanocomplex | |
KR20220101094A (en) | Functional food composition for visual function | |
Dawood et al. | Histological effect of COQ10 on liver and buccal mucosa in mice | |
Al-Assaf | Hepatoprotective and antioxidant effect of corosolic acid on carbon tetrachloride induced hepatotoxicity | |
FR2938733A1 (en) | Composition, useful e.g. as dietary supplement and to prevent and/or reduce the damage and/or muscle pain induced by physical activity, comprises L-carnitine and L-cysteine | |
WO2019110097A1 (en) | Composition comprising l-carnitine for the treatment of male infertility | |
FR3109723A1 (en) | Composition for strengthening and / or regulating the immune response |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |
Effective date: 20131231 |